Ultimate magazine theme for WordPress.

Top news from AMA Morning Rounds®: Week of October 4th, 2021

Read AMA Morning Rounds®’s most popular medical and public health stories from the week of October 4, 2021 through October. 8, 2021.

Diabetes, heart, and lung associations urge Americans to get both flu and COVID-19 vaccines ahead of flu season

Diabetes, heart, and lung associations urge Americans to get both flu and COVID-19 vaccines ahead of flu season

Healio (10/1) reported, “Three associations urge eligible individuals to get their annual flu shot and the COVID-19 vaccine to reduce hospital burden and protect those in need of protection ahead of the flu season.” A statement was made by “the American Heart Association, American Lung Association, and American Diabetes Association “published. According to an AHA press release, “patients with cancer, chronic lung disease, diabetes and heart disease are at greater risk of severe complications from severe respiratory illnesses like flu and COVID-19” and “according to the press release,” the 2021-2022 flu season could be severe and start early which means flu prevention is an important step in relieving overcrowded hospitals and protecting people at risk and at risk.

Young men at three times the risk of myocarditis after the second vaccination with Pfizer-BioNTech, Moderna COVID-19 vaccines compared to the first dose, study results

Young men at three times the risk of myocarditis after the second vaccination with Pfizer-BioNTech, Moderna COVID-19 vaccines compared to the first dose, study results

The New York Times (10/4, Mandavilli) reports research showing that “a second dose of the coronavirus vaccines manufactured by Pfizer-BioNTech and Moderna can nearly triple the likelihood of rare heart disease in young men,” but “that absolute risk “of the disease known as myocarditis remains extremely low.” In particular, after a second dose, “5.8 cases per million” were recorded in men around the age of 25, while after a first dose “0.8 Cases per million ”occurred. The Times also reports that the researchers “may have missed people whose heart problems were not severe enough to be hospitalized.” The results were published in JAMA Internal Medicine.

The incidence of anxiety and depression symptoms in U.S. adults increased during the winter COVID-19 surge, research has shown

The incidence of anxiety and depression symptoms in U.S. adults increased during the winter COVID-19 surge, research has shown

The New York Times (10/5, Mueller) reports, “The arrival of vaccines and the decline in COVID-19 cases in the first half of 2021 coincided with relief from symptoms of anxiety and depression in the” US, but “the symptoms remained severe”. in June 2021, the end of the survey period, more frequently than before the pandemic and could increase again due to the summer increase in the delta variant, CDC scientists said. The results were published online in the CDC’s Morbidity and Mortality Weekly Report.

The Hill (10/5, Coleman) reports: “The incidence of symptoms of anxiety and depression in American adults increased during the winter Covid-19 surge, according to a“ CDC ”study examining the psychological impact of the pandemic Health of the country shows. The study, which stretched from August 2020 to June 2021, found that the incidence of anxiety and depression peaked between December 2020 and January 2021, when COVID-19 cases shot to new heights during the holiday season. Despite a decline of 26.8% through June 2021, the researchers also found that “the incidence of anxiety and depression still remained” significantly “higher than it did before the pandemic”.

WHO recommends malaria vaccination for children in the hardest hit regions

WHO recommends malaria vaccination for children in the hardest hit regions

The Washington Post (10/6, Firozi, Iati, Cunningham) reports that on Wednesday the World Health Organization (WHO) “recommended the world’s first malaria prevention vaccine for widespread use in children, a tool that is supposed to help may, tens of thousands of lives each year. ”WHO said it recommends using the vaccine in children in locations with moderate to high levels of malaria transmission.

The New York Times (10/6, A1, Mandavilli) says GlaxoSmithKline’s novel vaccine “awakens a child’s immune system to thwart Plasmodium falciparum, the deadliest of five malaria pathogens and the most common in Africa.” It is estimated that the vaccine will “save tens of thousands of children every year. Malaria kills around half a million people every year, almost all of them in sub-Saharan Africa – including 260,000 children under the age of five. “

The AP (10/6, Cheng) reports, “WHO said its decision was based largely on the results of ongoing research in Ghana, Kenya and Malawi, which has tracked more than 800,000 children who have received the vaccine since 2019.” The shot has problems, however: it “is only about 30% effective, it takes up to four doses, and its protection wears off after several months.” Nonetheless, “scientists say the vaccine could have a major impact against malaria in Africa, wherever.” most of the world’s more than 200 million cases and 400,000 deaths per year are home to. “

Health professionals are concerned about the possibility of a severe flu season as many Americans say they may not receive a vaccine

Health professionals are concerned about the possibility of a severe flu season as many Americans say they may not receive a vaccine

The New York Times (10/7, Hoffman) reports, “Lockdowns helped keep last year’s flu season historically mild in both the United States and around the world, but US officials fear this fall and winter a more serious season of unmasked people and much more, and nearly half of adults in a new poll said they are unlikely to get the flu shot. ”On Thursday,“ top health experts said they were particularly concerned that almost one in four people at higher risk of flu-related complications said they did not intend to get the flu vaccine because the coronavirus is still spread across the country ”. CDC director Dr. Rochelle Walensky “noted that while experts did not yet know how badly the flu would hit the United States this fall, other respiratory infections had returned, including RSV, a common cause of pneumonia and bronchitis in babies and a serious threat to them older adults. “

USA Today (7/7, Miller) reports that the survey commissioned by the National Foundation for Infectious Diseases “found that while more than 60% of Americans agreed that the flu shot was the best way to reduce flu deaths and hospitalizations prevent it, 44% said they weren’t sure whether or not they wanted to get a flu vaccine this year. Public health experts are concerned that this “could make an above-average flu season worse”.

AMA Morning Rounds news coverage is developed in collaboration with Bulletin Healthcare LLC. Subscribe to the morning rounds daily.

High

Comments are closed.